Ultrasound could help evaluate diaphragm and respiratory function in people with late-onset Pompe disease (LOPD), a study…
Joana Carvalho, PhD
Joana holds a bachelor’s in biology, a Master of Science in evolutionary and developmental biology, and a PhD in biomedical sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — those that make up the lining of blood vessels — found in the umbilical cord of newborns. In addition to several research fellowships, she was awarded two Erasmus scholarships to conduct part of her studies in France.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Carvalho, PhD
Amicus Therapeutics has completed and exceeded patient enrollment for its Phase 3 PROPEL trial of…
Amicus Therapeutics announced that it has entered into a manufacturing agreement with Paragon Bioservices to drive the development of technologies,…
Scientists have discovered a genetic variant that might help explain why some people with Pompe disease experience their first…
Rare childhood disorders, including Pompe disease, pose a significant estimated impact on the quality of life of affected children and…